APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Healthcare
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • Healthcare
    • Sartorius
    Previous

    Sartorius: Empowering Biotech Scientists and Engineers across the Globe

    Follow Sartorius on :

    As the Healthcare Reform in China spreads nationwide to cut prices of drugs and improve their efficacy and safety, flourishing Chinese biotechnology companies are increasingly investing in new advances in gene and cell therapy. Bioventure companies are under mounting pressure to offer more personalized treatment while keeping up with increased regulations and quality standards in the market, driven by increased regulatory requirements globally and locally. In the wake of the growth in biosimilars markets and the shift to translational research, the push for innovation in the industry ushers in industrialization challenges coupled with heightened R&D standards and the requirement for more regulations. Evidently, when it comes to discovery in research, development, and production of biotherapeutics, it is a daunting task to increase speed to market and boost the productivity, all while ensuring the quality, purity, and integrity of the product. With a strong technical team throughout Asia, including service engineers and field application specialists across the APAC region, Sartorius, an international provider of laboratory and process technologies and equipment is changing this narrative. Through a wide range of innovative products and high-quality services, the company helps its customers in the biotech, pharmaceutical, and food industries implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time and cost-efficient manner.

    Built with a singular focus on science research, pharmaceutical, and biopharmaceutical manufacturing, Sartorius is well-positioned as a comprehensive solutions provider across the value chain from R&D, production, to in-process Quality Control (QC). “Covering the entire value-added chain of the biopharmaceutical, Sartorius products and services ensure novel therapies reach the market faster and are more accessible to more people worldwide,” mentions Grace Johnston, Head of Marketing at Sartorius.

    Sartorius Bioprocess Division provides innovative single-use products and equipment for the manufacture of biologics, enabling more efficient and less expensive production. Through the Bioprocess Solutions Division, Sartorius offers a broad product portfolio that covers all steps in the production of a biopharmaceutical. The company’s core technologies, such as filtration, fermentation, cell cultivation, and single-use bags and containers have been leading market positions for years. Sartorius’ Laboratory Products and Services Division, on the other hand, equips laboratories performing research and quality control with premium lab essentials—market-leading laboratory products, consumables, and services—to simplify workflows and advance speed to market.

    Sartorius’ revolutionary technologies including the iQue Screener PLUS provide rapid, multifactorial results to enable deeper insights and ensure the choice, quality, and integrity of the client’s biopharmaceutical product. Sartorius’ revolutionary technologies including the iQue Screener PLUS provide rapid, multifactorial results to enable deeper insights and ensure the choice, quality, and integrity of the client’s biopharmaceutical product.

    Covering the entire value-added chain of the biopharmaceutical, Sartorius products and services ensure novel therapies reach the market faster and are more accessible to more people worldwide


    “Keeping in mind that safety and compliance are critical in the sampling, detection and microbiological quantification processes, our microbiological QC portfolio—air monitoring, bioburden, and sterility testing—comprises fit-for-purpose, easy-to-use, and efficient tools that are specifically designed to help our customers monitor and reduce contamination risks,” mentions Sook Yee Loh, Head of Sales, Life Science Research, APAC at Sartorius. Collaboratively, both these divisions enable Sartorius’ customers to manufacture traditional drugs and biopharmaceuticals safely, more efficiently, and less expensively.

    As a trusted partner for the biopharmaceutical industry and laboratories, Sartorius plays a vital role in regulatory compliance along with providing tools that enable customers to stay at the cutting-edge of innovation. The uniqueness of Sartorius stems from its acquisitions of U.S. companies: IntelliCyt and Essen BioScience in the field of cell analytics. Powered by a combination of unique technologies in the area of high throughput (IntelliCyt) and real-time quantitative analysis (Essen), Sartorius’ unrivaled solutions provide significant benefits to biopharmaceuticals’ R&D workflows.

    Sartorius also continues to innovate in the space of lab weighing. Loh and Eirik Pettersen, Head of Sales, Applied Research, LPS Division, inform, “In March 2019, we launched Cubis II®, the next generation of modular premium balances for scientists in R&D and analytical laboratories needing the most reliable lab weighing results. Sartorius’s Cubis® II is the first balance that supports all requirements to achieve 21 CFR part 11 and EU Annex 11 compliance without needing a single sheet of paper and eliminating the possibility to falsify process data and/or signatures.”

    With over 8000 employees, Sartorius owns and operates production facilities in Europe, America, and Asia, as well as enjoys a presence in 110 counties. The corporate culture at the firm is shaped by three core values: sustainability, openness, and enjoyment. “These form the bedrock of our company’s innovative and competitive strength,” asserts Johnston. As for the future, Sartorius has aggressive expansion plans to optimally continue serving the growing needs in the market. In 2019, Sartorius is all set to complete the major part of its multi-year investment program to expand the production capacity of its manufacturing facilities and extend its group headquarters. “Furthermore, Sartorius’ strategic initiatives for 2025 in the APAC region will center on building upon our strong China market presence, adding high impact innovations to our product portfolio and extending our manufacturing base in Asia,” concludes Loh.
    Previous
    Share this Article:
    Tweet
    Share

    Sartorius Info

    Company
    Sartorius

    Headquarters
    .

    Management
    Joachim Kreuzburg, CEO & Chairman of the Executive Board

    Description
    Sartorius empowers scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine

    2019

    Sartorius News

    Employment of Latest Bioreactor Vessel for Gene and Cell Therapy Applications

    The new bioreactor vessel is designed for optimum growth and gentle stirring of cell lines, which is a cost-effective and scalable process in developing gene therapies and cell.

    FREMONT, CA: “Covering the entire value-added chain of biopharmaceuticals, Sartorius products and services ensure novel therapies reach the market faster and are more accessible to more people worldwide,” mentions Grace Johnston, Vice President Marketing at Sartorius while talking about the focus of the enterprise. Sartorius Stedium Biotech, a chief global partner of the biopharmaceutical industry recently announced the launch of a new vessel for its ambr 250 modular benchtop automated mini bioreactor system.
    Read More

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    CIO Speaks

    Previous Next
    The (E-) Doctor Is In: What Trends to Spot in Healthcare Technology Today

    Dickon Smart-Gill, CIO, Bumrungrad International Hospital

    How Healthy is Your IT?

    John Sutherland-CIO-Ramsay Health Care

    China Embracing Connected Health

    Geoff Feakes, Group CIO, Tunstall Healthcare

    Document Management in the Cloud

    Alex Choy, EVP R&D CIO, Change Healthcare

    Enterprise Architecture - An Extremely Valuable Discipline for Great Businesses

    Ken Spangler, SVP & CIO FedEx Ground and FedEx Freight, FedEx Services IT

    Analytics and AI in Healthcare

    Steven Parrish, CIO, Taranaki District Health Board

    The Right Technology And Reliable Partners; The Business Next Frontier

    Luke O'Brien, CIO, ISS Facility Services Australia & New Zealand

    Service Organisations Make Great Places To Work, And Deliver Better Value

    Matthew Perry, CIO, Orora Limited [ASX: ORA]

    How Have Recent Advancements in Big Data Been Impacting Businesses?

    Marc Solomon, CIO, Bvn Architecture

    BI & Analytics in Aquaculture

    Matthew Leary, CIO, Tassal Operations

    BI and Analytics

    Gary Peel, CIO, SYNERGY (ASX:IS3)

    A Blend of Six Technologies to Enhance Teaching-Learning Processes

    John Hui, CIO, The Education University of Hong Kong

    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://healthcare.apacciooutlook.com/vendor/sartorius-empowering-biotech-scientists-and-engineers-across-the-globe-cid-4069-mid-231.html